Neumora Therapeutics stock surges as Amgen confirmed as major shareholder

Neumora Therapeutics stock advanced as much as 16% in Wednesday morning’s trade after it was revealed that Amgen Inc (NASDAQ:AMGN) holds a material stake in the company.